NCT07372820 (METAB-HTX) is a clinical trial in Heart Transplantation, sponsored by Heinrich-Heine University, Duesseldorf.

Who is sponsoring NCT07372820?

NCT07372820 is sponsored by Heinrich-Heine University, Duesseldorf.

What condition does NCT07372820 study?

NCT07372820 studies Heart Transplantation.

Is NCT07372820 still recruiting?

NCT07372820 is currently recruiting now. Last updated 28 January 2026.

Last reviewed 2026-01-28 · How we verify

NCT07372820: METAB-HTX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

METABolic Deterioration in HTX Determines Outcomes

Recruiting now Last updated 28 January 2026

What this trial tests

trial in Heart Transplantation in 270 participants. Currently enrolling.

Timeline

24 July 2025

Primary endpoint
1 April 2030

1 February 2032

Quick facts

Lead sponsor	Heinrich-Heine University, Duesseldorf
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	270
Start date	24 July 2025
Primary completion	1 April 2030
Estimated completion	1 February 2032
Sites	1 location across Germany

Conditions studied

Heart Transplantation — all drugs for Heart Transplantation →

Sponsor

Heinrich-Heine University, Duesseldorf

Who can join

18 and older, any sex, with Heart Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heart Transplantation

Currently open trials in the same condition.

NCT07359690 — Multimodal Analysis of Endomyocardial Biopsies · recruiting
NCT07096973 — Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery · recruiting
NCT06982404 — ZeroHeart Biopsy - Prediction of Deceased Donor Heart Transplant Performance From Organ Donors Using Pre-Transplant Biop · recruiting
NCT07531784 — A National Swedish Study Evaluating Dd-cfDNA for as a Diagnostic Biomarker for Rejection Surveillence in Heart Transplan · recruiting
NCT06325280 — Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease · recruiting

Other Heinrich-Heine University, Duesseldorf trials

Trials by the same sponsor.

NCT04993508 — Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Co · NA · not yet recruiting
NCT07385482 — Chronic and Acute Cardiovascular Diseases in Elderly Intensive Care Patients · not yet recruiting
NCT07455097 — COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P) · active not recruiting
NCT07254663 — GEL & MEDication Dysphagia · recruiting
NCT06313944 — German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07372820 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heinrich-Heine University, Duesseldorf
Last refreshed: 28 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07372820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing